Paul W. Sandman
No más puestos en curso
Perfil
Paul W.
Sandman served as an Independent Director at PDL BioPharma, Inc. from 2008 to 2020.
Prior to that, he was the Secretary, Executive VP & General Counsel at Boston Scientific Corp.
from 1993 to 2008 and the Secretary, Senior Vice President & General Counsel at Wang Laboratories, Inc. from 1981 to 1993.
Sandman received his undergraduate degree from Boston College and his graduate degree from Harvard Law School.
Antiguos cargos conocidos de Paul W. Sandman.
| Empresas | Cargo | Fin |
|---|---|---|
| PDL BIOPHARMA, INC. | Director/Board Member | 15/01/2020 |
| BOSTON SCIENTIFIC CORPORATION | General Counsel | 29/02/2008 |
Wang Laboratories, Inc.
 Wang Laboratories, Inc. Information Technology ServicesTechnology Services Wang Laboratories, Inc. develops, markets, and supports software and provides integration and support services for computers. The company is based in Billerica, MA. Wang Laboratories was acquired by Getronics BV, part of Bottega InvestCo SARL from July 07, 2017 on June 08, 1999 for $1,376.08 million. | General Counsel | 01/04/1993 |
Formación de Paul W. Sandman.
| Boston College | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| Empresas privadas | 2 |
|---|---|
Wang Laboratories, Inc.
Wang Laboratories, Inc. Information Technology ServicesTechnology Services Wang Laboratories, Inc. develops, markets, and supports software and provides integration and support services for computers. The company is based in Billerica, MA. Wang Laboratories was acquired by Getronics BV, part of Bottega InvestCo SARL from July 07, 2017 on June 08, 1999 for $1,376.08 million. | Technology Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
- Bolsa de valores
- Insiders
- Paul W. Sandman
